Halozyme Therapeutics, Inc.: JP Morgan raises target price to $79 from $78
HALO•JP Morgan raised its target price for Halozyme Therapeutics to $79 from $78.
Related News
Circle Internet Group target price raised to $110 from $105 by JP Morgan
CRCL•
Inspire Medical Systems, Inc.: Jefferies raises target price to $60 from $55
INSP•
Emerson: Morgan Stanley cuts target price to $140 from $145
EMR•
CommBank forecasts record 14% peak-to-trough fall in Australian home prices
CMWAY•
Morgan Stanley is a dubious saviour for UBS
UBS•